Corbion NV
AEX:CRBN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (8.9), the stock would be worth €24.34 (36% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.5 | €17.95 |
0%
|
| 3-Year Average | 8.9 | €24.34 |
+36%
|
| 5-Year Average | 10.5 | €28.84 |
+61%
|
| Industry Average | 6.9 | €19.05 |
+6%
|
| Country Average | 12.4 | €33.97 |
+89%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
€1.4B
|
/ |
Jan 2026
€204.3m
|
= |
|
|
€1.4B
|
/ |
Dec 2026
€220.2m
|
= |
|
|
€1.4B
|
/ |
Dec 2027
€234.3m
|
= |
|
|
€1.4B
|
/ |
Dec 2028
€249m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| NL |
|
Corbion NV
AEX:CRBN
|
1B EUR | 6.5 | 13.8 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
83B USD | 20.9 | 32.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.4T JPY | 12.6 | 25.6 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
75.8B USD | 21.3 | 36.5 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 5.8 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
274.5B CNY | 21.2 | 24.7 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26.4B CHF | 16.9 | 24.2 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 38.3 | 63.7 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 28.9 | 54.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
25B USD | 10.9 | 15.8 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 10.3 | 17.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7.9 |
| Median | 12.4 |
| 70th Percentile | 19.3 |
| Max | 706 |
Other Multiples
Corbion NV
Glance View
In the bustling world of biochemicals, Corbion NV emerges as a leader, deeply rooted in its Dutch origin yet boldly branching into global markets. Founded with a forward-thinking vision, the company has carved a niche in the sustainable solutions sector, primarily through its expertise in lactic acid and its derivatives. Corbion operates with a keen focus on innovation, leveraging its scientific prowess to transform renewable resources into high-demand food ingredients, biochemical solutions, and bioplastics. Serving industries that range from food preservation to personal care, the company's products are woven into the fabric of everyday life, delivering both functional benefits and a compelling narrative of sustainability. Corbion’s business model thrives on its ability to blend cutting-edge research with consumer needs, capitalizing on the growing demand for natural and eco-friendly alternatives. The company's revenue streams are neatly balanced between its two core segments: Ingredients Solutions, where it provides essential products for food and industry, and Innovation Platforms, which focuses on leveraging biotechnology to propel future growth, including in bioplastics and algae-based applications. By consistently aligning its operations with the shifting tides of consumer consciousness towards sustainability and health, Corbion not only preserves its competitive edge but also positions itself as a harbinger of change in the movement towards a more sustainable planet.